UCB Mergers and Acquisitions Summary

Healthcare ServicesCompany

UCB has acquired 10 companies, including 4 in the last 5 years. It has also divested 7 assets.

UCB’s largest acquisition to date was in 2006, when it acquired Schwarz Pharma AG for $5.6B. It’s largest disclosed sale occurred in 2015, when it sold Kremers Urban Pharmaceuticals to Lannett Company for $1.2B. UCB has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (60%) and medical products (30%).

Join Mergr and gain access to UCB’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.

M&A Summary

  • M&A Total Activity17
    • M&A Buy Activity10
    • M&A Sell Activity7
  • Total Sectors Invested 3
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 8
  • M&A Advisors 6

UCB

UCB S.A.

Allee de la Recherche, 60,
Brussels, 1070
Belgium,
+32 2 559 99 99
www.ucb.com

UCB is a biopharma focused on severe diseases with operations in approximately 40 countries. UCB incorporated in 1928 and is based in Brussels, Belgium.


M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.6/yr) # 7 - 1 1 - 1 10
vol $8.4B $2.5B $270M $1.9B $13.1B
Sell (0.2/yr) # 6 1 - - - - 7
vol $2.1B $2.1B
  17

Most Recent M&A

Company Date Value Type
Zogenix, Inc. 2022-01-19 1.9B USD Add-on Acquisition
Emeryville, California · www.zogenix.com
Engage Therapeutics, Inc. 2020-06-05 270M USD Add-on Acquisition
Summit, New Jersey · www.engagetherapeutics.com
Ra Pharmaceuticals, Inc. 2019-10-10 2.5B USD Add-on Acquisition
Cambridge, Massachusetts · www.rapharma.com
APONTIS PHARMA GmbH & Co. KG 2018-07-30 - Divestiture
Monheim am Rhein, Germany · www.apontis-pharma.de
Beryllium Discovery LLC 2017-06-06 - Add-on Acquisition
Bedford, Massachusetts · www.be4.com
International Medication Systems (UK) Ltd. 2016-08-04 8M USD Divestiture
Berkshire, United Kingdom
UCB - Three Cardiovascular Products 2016-02-01 104M EUR Divestiture
, Belgium
Kremers Urban Pharmaceuticals, Inc. 2015-11-27 1.2B USD Divestiture
Princeton, New Jersey · www.kremersurban.com
Lectus Therapeutics - Pharmaceutical Assets 2011-11-22 - Divestiture
, United Kingdom
UCB - Pharmaceutical Brands 2009-01-22 580M EUR Divestiture
, Belgium
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 6 (60%) 5.2B (40%) 6 (86%) 2.0B (95%)
Medical Products 3 (30%) 5.6B (43%) 1 (14%) 104M (5%)
Healthcare Services 1 (10%) 2.3B (18%) - -
Total 10 $13.1B 7 $2.1B

By Geo

State/Country Buy Value Sell Value
United States 7 5.2B 1 1.2B
  Massachusetts 2 2.5B - -
  Georgia 2 - - -
  New Jersey 1 270M 1 1.2B
  Missouri 1 500M - -
  California 1 1.9B - -
Belgium - - 3 819M
United Kingdom 2 2.3B 1 8M
Germany 1 5.6B 1 -
France - - 1 -
Domestic - - 3 (43%) 819M (40%)
Cross-border 10 (100%) 13.1B (100%) 4 (57%) 1.2B (60%)
Total 10 $13.1B 7 $2.1B

Top M&A Advisors

Financial Deals
Lazard Ltd.
3
Barclays Investment Bank
1
Daiwa Corporate Advisory Ltd. (DC Advisory)
1
Legal Deals
Covington & Burling LLP
3
Hengeler Mueller
1

Deal Values

buy # Total
> $1B 4 $12.3B
$100M to $1B 2 $770M
TOTAL $13.1B
Largest Schwarz Pharma AG
$5.6B (2006-09-26)
sell # Total
> $1B 1 $1.2B
$100M to $1B 3 $819M
< $100M 1 $8M
TOTAL $2.1B
Largest Kremers Urban Pharmaceuticals, Inc.
$1.2B (2015-11-27)

M&A Connections

Deals
Acquired from
Strategic(s)
20%
2 (20%)
Divested to
Investor(s)
14%
1 (14%)
Strategic(s)
71%
5 (71%)

 Subscribe to unlock this and 179,815
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 170K M&A Transactions
  • 175K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.